Mueller Industries (MLI) reported a year-over-year increase in fiscal Q3 adjusted diluted earnings and net sales late Monday.

Shares jumped 16%, with intraday trading volume at over 1.17 million compared with a daily average of about 777,000.

Indaptus Therapeutics (INDP) disclosed a clinical supply agreement late Tuesday with BeiGene (BGNE).

Indaptus plans to advance human clinical evaluation of a combination of BeiGene's anti-PD-1 antibody, tislelizumab, with its Decoy20, a novel treatment designed to induce a broad immune response to fight cancer. As part of the agreement, BeiGene will also provide technical expertise to accelerate the first clinical trial combining the two investigational drugs.

Shares of Indaptus advanced 16% as intraday trading volume climbed to over 4.03 million from a daily average of about 17,000.

General Motors (GM) reported a year-over-year jump in Q3 adjusted earnings and revenue, beating market expectations.

Shares jumped 9.2% as intraday trading volume surged to more than 28.1 million from a daily average of about 13.6 million.

Price: 83.72, Change: +11.64, Percent Change: +16.14